Peptides surge in popularity for anti-aging, but a dark gray market poses serious risks. Experts call for oversight. GLP-1 agonists like semaglutide spark a peptide revolution, but unapproved compound...
Exploring the rise of BPC-157 peptide therapy for tissue repair, its safety in recent studies, and the ethical dilemmas surrounding its unregulated use. As BPC-157 gains traction for tendon and muscle...